Hospital Acquired Infection Control Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The Hospital Acquired Infection Control Market is poised for substantial growth, with worldwide revenue reaching US$ 6.8 Billion in 2024 and anticipated to propel the market to US$ 9.6 Billion by the end of 2031, according to the latest report by Fairfield Market Research.
Changing Healthcare Infrastructure and the Demand for Infection Control
Over the past decade, the healthcare landscape has undergone significant transformations, marked by the adoption of advanced medical technologies. As the prevalence of infectious and chronic diseases has surged, the need for disinfection and sterilization equipment has never been more critical.
Driving Factors for Hospital Acquired Infection Control Market Expansion
Several factors are contributing to the growing demand for hospital-acquired infection control technology:
• Rising Public Awareness: Increasing awareness about healthcare-associated infections among the public is driving the need for infection control measures.
• Government Initiatives: Government programs aimed at strengthening infection control systems in medical facilities are playing a pivotal role in market expansion.
• Prevalence of Infectious Diseases: The rising incidence of infectious and communicable diseases is fueling the demand for infection control technology.
• Impact of COVID-19: The pandemic underscored the importance of infection control in healthcare settings, leading to increased demand for related equipment.
Manufacturers Expanding Their Markets
Manufacturers in the hospital acquired infection control market are expanding their reach through various strategies:
• Increased awareness about personal hygiene is driving the demand for sterilized medical equipment, especially as the number of surgical procedures rises.
• The demand for nosocomial infection control equipment is growing as people recognize the benefits of sterilization.
• Minimally invasive procedures and the rise of outpatient services are contributing to market growth.
• Increasing government initiatives and growing public awareness are expanding the number of outpatients, further driving market progress.
Challenges in Market Progress
While the hospital acquired infection control market holds immense potential, challenges exist:
• The complexity of infection control methods and the need for advanced technologies can be obstacles.
• Reprocessing technology for medical devices poses challenges in ensuring their safety for reuse, affecting market expansion to some extent.
Booming Market in the United States
The United States presents a highly lucrative market for hospital-acquired infection control equipment due to its advanced healthcare system, high healthcare costs, and widespread public awareness of infection control issues. It is expected to generate a significant share of the region's revenue.
Emerging Market in China
China is emerging as a prominent market for hospital-acquired infection control, driven by increasing public awareness of hospital-acquired infections, government support programs, and a rising number of such infections. China is expected to dominate in terms of revenue share.
Focus on India
India, as the second-most populous country in the world, offers substantial potential for hospital-acquired infection control equipment suppliers. As hygiene awareness and attention to healthcare intensify, India is likely to experience significant growth in demand for disinfection equipment. The nation's healthcare infrastructure is expected to advance rapidly over the next decade, presenting opportunities for local market players.
Competitive Landscape
The healthcare-associated infections segment has gained significant attention, prompting key industry players to invest in research and development and launch new products. Some key companies profiled in the hospital acquired infection control market include Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, Bayer AG, Alere Inc., The 3M Company, Cepheid Inc., and UVision360 Inc.
Market Segmentation
By Product :
• Heat Sterilization Equipment
Moist Heat Sterilization Equipment
Dry Heat Sterilization Equipment
• Low-Temperature Sterilization Equipment
• Radiation Sterilization Equipment
• Disinfection Equipment
Disinfector
Washer Disinfector
Flusher Disinfector
Endoscopic Reprocessor Systems
Single Basin Endoscopic Reprocessor Systems
Dual Basin Endoscopic Reprocessor Systems
Disinfectants
By End User :
• Hospitals
• Ambulatory Surgical Centres
• Medical Institutions
• Diagnostic Laboratories
• Clinics
By Region :
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.